Monoclonal antibody therapy of inflammatory bowel disease. S.J.H. van DeventerL. Camoglio OriginalPaper Pages: 55 - 59
Antiepileptic drug treatment in the nineties in The Netherlands. D.G.A. Kasteleijn‐Nolst TrenitÄP.M. Edelbroek OriginalPaper Pages: 60 - 69
Are SSRIs true antidepressant drugs? a plea for the re-evaluation of their therapeutic potential and safety. Anton J.M. Kasteleijn‐Nolst TrenitÄ OriginalPaper Pages: 70 - 72
Pharmacoeconomics: where is the link with pharmacokinetics and biopharmaceutics? Frank Peys OriginalPaper Pages: 73 - 81
Lifestyle, fibrinolysis and lipids. E.J.P BrommerJ.A. Gevers LeuvenP. Brakman OriginalPaper Pages: 82 - 88
The anaesthetist as determinant factor of quality of surgical antimicrobial prophylaxis. A survey in a university hospital. I.C. GyssensJ.T.A. KnapeJ.W.M. van der Meer OriginalPaper Pages: 89 - 92
Consumption of anti‐infective drugs in Bulgaria for the period from 1979 to 1994. Maria PopovaGuenka Guencheva OriginalPaper Pages: 93 - 100
Patient‐oriented Pharmacy on a Special Ward. Results of a pilot project in Germany. Andrea LitzingerReinhild Rohde‐Boehler OriginalPaper Pages: 101 - 104
An evaluation of community pharmacy records in the development of pharmaceutical care in The Netherlands. H. RahimtoolaS. HudsonR. Dessing OriginalPaper Pages: 105 - 113
Interaction between the Drug Information Centre and the Regional Centre for Adverse Drug Reaction Monitoring in Northern Sweden. Torborg Nordkvist OlssonMartin BäckströmTom Mjörndal OriginalPaper Pages: 114 - 115
